Cargando…
Levosimendan: current data, clinical use and future development
Levosimendan is an inodilator indicated for the short-term treatment of acutely decompensated severe chronic heart failure, and in situations where conventional therapy is not considered adequate. The principal pharmacological effects of levosimendan are (a) increased cardiac contractility by calciu...
Autores principales: | Nieminen, M S, Fruhwald, S, Heunks, L M A, Suominen, P K, Gordon, A C, Kivikko, M, Pollesello, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
EDIMES Edizioni Internazionali Srl
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868185/ https://www.ncbi.nlm.nih.gov/pubmed/24364017 |
Ejemplares similares
-
Interaction between renal function and the effect of levosimendan on long-term mortality of patients with low-output heart failure
por: Cleland, J, et al.
Publicado: (2003) -
Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018) -
Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018) -
Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004) -
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use
por: Papp, Zoltán, et al.
Publicado: (2020)